Hervolution Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $11,700,000
Company Info
- Founders
- J.Robert Coleman, PhD, MBA
- Company Description
- Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).
- Market
- Healthcare
- Location
- Copenhagen, Denmark
- Coinvestors
- Serum Institute of India, European Innovation Council Fund